Skip to main content
Cellid Co., Ltd. logo

Cellid Co., Ltd. — Investor Relations & Filings

Ticker · 299660 ISIN · KR7299660001 KO Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2025-06-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 299660

About Cellid Co., Ltd.

http://www.cellid.co.kr

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding a capital increase through a rights offering (주주배정 유상증자). It details the number of shares issued, the total amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2025-06-24 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a capital increase (유상증자), including subscription status, allocation, and the use of proceeds. This is a standard regulatory filing for companies that have completed a public offering of securities. It does not fit into the 'Annual Report' or 'Earnings Release' categories, but rather serves as a formal post-issuance disclosure required by financial regulators.
2025-06-24 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding the results of a paid-in capital increase (rights offering and general public offering). It details the subscription results, including the number of shares subscribed, subscription rates, and future schedules for payment and listing. This falls under the category of capital and financing updates as it relates to the company's capital structure changes.
2025-06-23 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the results of a rights offering (paid-in capital increase). It details the subscription results, including the number of shares subscribed, the subscription rate, and the handling of unsubscribed shares. This falls under the category of capital structure changes and share issuance announcements.
2025-06-18 Korean
유상증자최종발행가액확정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Cellid regarding the finalization of the issue price for a paid-in capital increase (rights offering). It details the number of shares, the final price per share, and the calculation methodology used to determine this price. This falls under the category of capital structure changes and financing updates, specifically related to share issuance.
2025-06-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a 'Decision on Paid-in Capital Increase' (유상증자 결정). It details the amendment of share issuance prices, the purpose of funds, and the subscription process. This falls under the category of announcements regarding new share issues or capital changes.
2025-06-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.